Do analysts recommend UFPT or BLCO?

Bausch + Lomb has a consensus price target of $18.75, indicating a potential upside of 3.99%. Given Bausch + Lomb's stronger consensus rating and higher possible upside, analysts plainly believe Bausch + Lomb is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Bausch + Lomb 1 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.31

Does the media favor UFPT or BLCO?

In the previous week, UFP Technologies had 1 more articles in the media than Bausch + Lomb. MarketBeat recorded 3 mentions for UFP Technologies and 2 mentions for Bausch + Lomb. UFP Technologies' average media sentiment score of 1.54 beat Bausch + Lomb's score of 0.37 indicating that UFP Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UFP Technologies 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Bausch + Lomb 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend UFPT or MMSI?

Merit Medical Systems has a consensus target price of $100.00, suggesting a potential upside of 11.61%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe Merit Medical Systems is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Merit Medical Systems 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.83

Does the media prefer UFPT or MMSI?

In the previous week, Merit Medical Systems had 6 more articles in the media than UFP Technologies. MarketBeat recorded 9 mentions for Merit Medical Systems and 3 mentions for UFP Technologies. UFP Technologies' average media sentiment score of 1.54 beat Merit Medical Systems' score of 1.26 indicating that UFP Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UFP Technologies 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Merit Medical Systems 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ICUI or UFPT?

ICU Medical currently has a consensus price target of $192.80, indicating a potential upside of 15.05%. Given ICU Medical's stronger consensus rating and higher probable upside, analysts clearly believe ICU Medical is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ICU Medical 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 2 Strong Buy rating(s) 2.89 UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media refer more to ICUI or UFPT?

In the previous week, ICU Medical had 4 more articles in the media than UFP Technologies. MarketBeat recorded 7 mentions for ICU Medical and 3 mentions for UFP Technologies. UFP Technologies' average media sentiment score of 1.54 beat ICU Medical's score of 0.87 indicating that UFP Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ICU Medical 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive UFP Technologies 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts rate UFPT or NVST?

Envista has a consensus price target of $29.71, indicating a potential upside of 9.57%. Given Envista's stronger consensus rating and higher possible upside, analysts clearly believe Envista is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Envista 0 Sell rating(s) 8 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.56

Does the media prefer UFPT or NVST?

In the previous week, Envista had 11 more articles in the media than UFP Technologies. MarketBeat recorded 14 mentions for Envista and 3 mentions for UFP Technologies. UFP Technologies' average media sentiment score of 1.54 beat Envista's score of 0.94 indicating that UFP Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment UFP Technologies 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Envista 6 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend NEOG or UFPT?

Neogen currently has a consensus target price of $12.00, indicating a potential upside of 1.44%. Given Neogen's stronger consensus rating and higher probable upside, equities research analysts plainly believe Neogen is more favorable than UFP Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neogen 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 UFP Technologies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is NEOG or UFPT more profitable?

UFP Technologies has a net margin of 11.45% compared to Neogen's net margin of -0.91%. UFP Technologies' return on equity of 18.42% beat Neogen's return on equity. Company Net Margins Return on Equity Return on Assets Neogen -0.91% 2.78% 1.74% UFP Technologies 11.45% 18.42% 11.96%

Does the media refer more to NEOG or UFPT?

In the previous week, Neogen had 1 more articles in the media than UFP Technologies. MarketBeat recorded 4 mentions for Neogen and 3 mentions for UFP Technologies. UFP Technologies' average media sentiment score of 1.54 beat Neogen's score of 0.95 indicating that UFP Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neogen 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive UFP Technologies 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

UFP Technologies (UFPT) Competitors

$288.79 +2.27 (+0.79%)

As of 09/4/2026 04:00 PM Eastern

Compare

UFPT vs. BLCO, MMSI, ICUI, NVST, and NEOG

Should you buy UFP Technologies stock or one of its competitors? UFP Technologies's main competitors and comparable companies include Bausch + Lomb (BLCO), Merit Medical Systems (MMSI), ICU Medical (ICUI), Envista (NVST), and Neogen (NEOG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does UFP Technologies compare to Bausch + Lomb?

UFP Technologies (NASDAQ:UFPT) and Bausch + Lomb (NYSE:BLCO) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

UFP Technologies has a net margin of 11.45% compared to Bausch + Lomb's net margin of -3.21%. UFP Technologies' return on equity of 18.42% beat Bausch + Lomb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UFP Technologies	11.45%	18.42%	11.96%
Bausch + Lomb	-3.21%	4.14%	1.93%

Bausch + Lomb has a consensus price target of $18.75, indicating a potential upside of 3.99%. Given Bausch + Lomb's stronger consensus rating and higher possible upside, analysts plainly believe Bausch + Lomb is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Bausch + Lomb	1 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.31

87.3% of UFP Technologies shares are held by institutional investors. Comparatively, 11.1% of Bausch + Lomb shares are held by institutional investors. 4.6% of UFP Technologies shares are held by insiders. Comparatively, 1.5% of Bausch + Lomb shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

UFP Technologies has higher earnings, but lower revenue than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UFP Technologies	$602.80M	3.71	$68.31M	$9.28	31.12
Bausch + Lomb	$5.10B	1.26	-$360M	-$0.48	N/A

In the previous week, UFP Technologies had 1 more articles in the media than Bausch + Lomb. MarketBeat recorded 3 mentions for UFP Technologies and 2 mentions for Bausch + Lomb. UFP Technologies' average media sentiment score of 1.54 beat Bausch + Lomb's score of 0.37 indicating that UFP Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UFP Technologies	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Bausch + Lomb	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

UFP Technologies has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market. Comparatively, Bausch + Lomb has a beta of 0.56, indicating that its share price is 44% less volatile than the broader market.

Summary

UFP Technologies beats Bausch + Lomb on 12 of the 16 factors compared between the two stocks.

How does UFP Technologies compare to Merit Medical Systems?

UFP Technologies (NASDAQ:UFPT) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability and analyst recommendations.

87.3% of UFP Technologies shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 4.6% of UFP Technologies shares are owned by insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

UFP Technologies has a beta of 1.08, suggesting that its share price is 8% more volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.49, suggesting that its share price is 51% less volatile than the broader market.

In the previous week, Merit Medical Systems had 6 more articles in the media than UFP Technologies. MarketBeat recorded 9 mentions for Merit Medical Systems and 3 mentions for UFP Technologies. UFP Technologies' average media sentiment score of 1.54 beat Merit Medical Systems' score of 1.26 indicating that UFP Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UFP Technologies	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Merit Medical Systems	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Merit Medical Systems has a consensus target price of $100.00, suggesting a potential upside of 11.61%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, analysts clearly believe Merit Medical Systems is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Merit Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83

Merit Medical Systems has higher revenue and earnings than UFP Technologies. UFP Technologies is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UFP Technologies	$602.80M	3.71	$68.31M	$9.28	31.12
Merit Medical Systems	$1.52B	3.53	$128.49M	$2.42	37.02

UFP Technologies has a net margin of 11.45% compared to Merit Medical Systems' net margin of 9.22%. UFP Technologies' return on equity of 18.42% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UFP Technologies	11.45%	18.42%	11.96%
Merit Medical Systems	9.22%	13.75%	8.10%

Summary

Merit Medical Systems beats UFP Technologies on 9 of the 17 factors compared between the two stocks.

How does UFP Technologies compare to ICU Medical?

ICU Medical (NASDAQ:ICUI) and UFP Technologies (NASDAQ:UFPT) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership.

96.1% of ICU Medical shares are held by institutional investors. Comparatively, 87.3% of UFP Technologies shares are held by institutional investors. 2.1% of ICU Medical shares are held by company insiders. Comparatively, 4.6% of UFP Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

UFP Technologies has a net margin of 11.45% compared to ICU Medical's net margin of 1.39%. UFP Technologies' return on equity of 18.42% beat ICU Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ICU Medical	1.39%	7.91%	4.17%
UFP Technologies	11.45%	18.42%	11.96%

UFP Technologies has lower revenue, but higher earnings than ICU Medical. UFP Technologies is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ICU Medical	$2.23B	1.88	$730K	$1.18	142.02
UFP Technologies	$602.80M	3.71	$68.31M	$9.28	31.12

In the previous week, ICU Medical had 4 more articles in the media than UFP Technologies. MarketBeat recorded 7 mentions for ICU Medical and 3 mentions for UFP Technologies. UFP Technologies' average media sentiment score of 1.54 beat ICU Medical's score of 0.87 indicating that UFP Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ICU Medical	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
UFP Technologies	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

ICU Medical currently has a consensus price target of $192.80, indicating a potential upside of 15.05%. Given ICU Medical's stronger consensus rating and higher probable upside, analysts clearly believe ICU Medical is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ICU Medical	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.89
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

ICU Medical has a beta of 0.75, indicating that its share price is 25% less volatile than the broader market. Comparatively, UFP Technologies has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market.

Summary

UFP Technologies beats ICU Medical on 9 of the 17 factors compared between the two stocks.

How does UFP Technologies compare to Envista?

UFP Technologies (NASDAQ:UFPT) and Envista (NYSE:NVST) are both mid-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

UFP Technologies has a net margin of 11.45% compared to Envista's net margin of 3.33%. UFP Technologies' return on equity of 18.42% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UFP Technologies	11.45%	18.42%	11.96%
Envista	3.33%	7.88%	4.33%

UFP Technologies has higher earnings, but lower revenue than Envista. UFP Technologies is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UFP Technologies	$602.80M	3.71	$68.31M	$9.28	31.12
Envista	$2.72B	1.60	$47M	$0.58	46.76

87.3% of UFP Technologies shares are owned by institutional investors. 4.6% of UFP Technologies shares are owned by insiders. Comparatively, 1.0% of Envista shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Envista had 11 more articles in the media than UFP Technologies. MarketBeat recorded 14 mentions for Envista and 3 mentions for UFP Technologies. UFP Technologies' average media sentiment score of 1.54 beat Envista's score of 0.94 indicating that UFP Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
UFP Technologies	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Envista	6 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Envista has a consensus price target of $29.71, indicating a potential upside of 9.57%. Given Envista's stronger consensus rating and higher possible upside, analysts clearly believe Envista is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Envista	0 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.56

UFP Technologies has a beta of 1.08, indicating that its stock price is 8% more volatile than the broader market. Comparatively, Envista has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market.

Summary

UFP Technologies beats Envista on 10 of the 17 factors compared between the two stocks.

How does UFP Technologies compare to Neogen?

Neogen (NASDAQ:NEOG) and UFP Technologies (NASDAQ:UFPT) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.

Neogen currently has a consensus target price of $12.00, indicating a potential upside of 1.44%. Given Neogen's stronger consensus rating and higher probable upside, equities research analysts plainly believe Neogen is more favorable than UFP Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neogen	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
UFP Technologies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

96.7% of Neogen shares are held by institutional investors. Comparatively, 87.3% of UFP Technologies shares are held by institutional investors. 0.5% of Neogen shares are held by insiders. Comparatively, 4.6% of UFP Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Neogen had 1 more articles in the media than UFP Technologies. MarketBeat recorded 4 mentions for Neogen and 3 mentions for UFP Technologies. UFP Technologies' average media sentiment score of 1.54 beat Neogen's score of 0.95 indicating that UFP Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neogen	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
UFP Technologies	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

UFP Technologies has a net margin of 11.45% compared to Neogen's net margin of -0.91%. UFP Technologies' return on equity of 18.42% beat Neogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neogen	-0.91%	2.78%	1.74%
UFP Technologies	11.45%	18.42%	11.96%

UFP Technologies has lower revenue, but higher earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neogen	$870.40M	2.96	-$7.90M	-$0.03	N/A
UFP Technologies	$602.80M	3.71	$68.31M	$9.28	31.12

Neogen has a beta of 1.76, suggesting that its share price is 76% more volatile than the broader market. Comparatively, UFP Technologies has a beta of 1.08, suggesting that its share price is 8% more volatile than the broader market.

Summary

UFP Technologies beats Neogen on 9 of the 16 factors compared between the two stocks.

Get UFP Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UFPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

UFPT vs. The Competition

Export

Metric	UFP Technologies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.24B	$5.76B	$7.25B	$12.92B
Dividend Yield	N/A	1.76%	2.53%	9.14%
P/E Ratio	31.12	25.82	273.54	25.43
Price / Sales	3.71	73.52	630.97	107.01
Price / Cash	23.37	32.98	77.08	52.44
Price / Book	4.84	6.06	12.85	6.17
Net Income	$68.31M	$150.92M	$3.49B	$350.08M
7 Day Performance	-3.75%	-1.22%	1.04%	-0.14%
1 Month Performance	-7.40%	2.18%	5.39%	0.94%
1 Year Performance	39.32%	9.95%	24.18%	14.02%

UFP Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
UFPT UFP Technologies	1.9325 of 5 stars	$288.79 +0.8%	N/A	+39.3%	$2.24B	$602.80M	31.12	5,349	Positive News
BLCO Bausch + Lomb	3.3311 of 5 stars	$17.46 +1.8%	$18.75 +7.4%	+20.2%	$6.13B	$5.10B	N/A	13,000
MMSI Merit Medical Systems	3.8934 of 5 stars	$90.66 +0.2%	$100.00 +10.3%	-3.6%	$5.40B	$1.52B	37.46	7,500	Positive News
ICUI ICU Medical	3.8484 of 5 stars	$172.95 -1.2%	$192.80 +11.5%	+27.7%	$4.38B	$2.23B	146.57	13,000	Insider Trade
NVST Envista	3.4568 of 5 stars	$27.13 flat	$29.31 +8.0%	+27.4%	$4.36B	$2.72B	46.78	12,000	News Coverage Positive News Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:UFPT) was last updated on 9/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UFP Technologies (UFPT) Competitors

UFPT vs. BLCO, MMSI, ICUI, NVST, and NEOG

How does UFP Technologies compare to Bausch + Lomb?

Summary

How does UFP Technologies compare to Merit Medical Systems?

Summary

How does UFP Technologies compare to ICU Medical?

Summary

How does UFP Technologies compare to Envista?

Summary

How does UFP Technologies compare to Neogen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UFPT vs. The Competition

UFP Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

UFP Technologies (UFPT) Competitors

UFPT vs. BLCO, MMSI, ICUI, NVST, and NEOG

How does UFP Technologies compare to Bausch + Lomb?

Is UFPT or BLCO more profitable?

Do analysts recommend UFPT or BLCO?

Do insiders and institutionals believe in UFPT or BLCO?

Which has better earnings and valuation, UFPT or BLCO?

Does the media favor UFPT or BLCO?

Which has more risk and volatility, UFPT or BLCO?

Summary

How does UFP Technologies compare to Merit Medical Systems?

Do insiders and institutionals have more ownership in UFPT or MMSI?

Which has more risk and volatility, UFPT or MMSI?

Does the media prefer UFPT or MMSI?

Do analysts recommend UFPT or MMSI?

Which has higher earnings and valuation, UFPT or MMSI?

Is UFPT or MMSI more profitable?

Summary

How does UFP Technologies compare to ICU Medical?

Do insiders & institutionals believe in ICUI or UFPT?

Is ICUI or UFPT more profitable?

Which has better valuation and earnings, ICUI or UFPT?

Does the media refer more to ICUI or UFPT?

Do analysts prefer ICUI or UFPT?

Which has more risk & volatility, ICUI or UFPT?

Summary

How does UFP Technologies compare to Envista?

Is UFPT or NVST more profitable?

Which has stronger valuation and earnings, UFPT or NVST?

Do institutionals & insiders believe in UFPT or NVST?

Does the media prefer UFPT or NVST?

Do analysts rate UFPT or NVST?

Which has more risk & volatility, UFPT or NVST?

Summary

How does UFP Technologies compare to Neogen?

Do analysts recommend NEOG or UFPT?

Do institutionals and insiders believe in NEOG or UFPT?

Does the media refer more to NEOG or UFPT?

Is NEOG or UFPT more profitable?

Which has stronger earnings & valuation, NEOG or UFPT?

Which has more risk and volatility, NEOG or UFPT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UFPT vs. The Competition

UFP Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools